Clinical Trial Update: Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting biomarker changes in a Phase 1/Phase 2 study of synergistic prostaglandin inhibitors for breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Hartford Hospital | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED